QualityStocksNewsBreaks Archives - Page 1484 of 1647

FridayAug 24, 2018 2:44 pm

QualityStocksNewsBreaks – Zenosense, Inc.’s (ZENO) MIDS Cardiac™ Uniquely Designed to Provide Lab-Comparable Accuracy in Minutes at Point of Care

Zenosense’s (OTC: ZENO) MIDS Cardiac™ may prove revolutionary in the niche cardiac diagnostic testing market, currently valued between $2 and $6 billion in the U.S. A recent article discussing this, reads “MIDS Cardiac™ is unique, because the technology is being developed to detect very low levels of cardiac markers to deliver accuracy that’s equal or superior to expensive state-of-the-art central laboratory analyzers, all while being accessible at the point of care and offering results within minutes.” To view the full article, visit http://ibn.fm/AYvAL About Zenosense, Inc. Zenosense Inc., through a joint-venture ownership in MIDS Medical Ltd., is primarily focused on…

FridayAug 24, 2018 2:10 pm

QualityStocksNewsBreaks – QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Firing Up Efforts to Ramp Up Irgon Lithium Mine Project Amidst Booming Global Market

QMC Quantum Minerals (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) is firing up North American lithium exploration and development efforts amidst a global market projected to reach $1.7 billion in 2019 (http://ibn.fm/nz4VH). A recent article discussing this reads, “This optimistic forecast coincides with QMC Quantum Minerals’ efforts to evaluate and revitalize its 100 percent-owned Irgon Lithium Mine Project. The property presents the prospect of a quick production ramp up once the company establishes market potential, particularly as part of the initial exploration and development 65 years ago, a 500-ton-per-day mill was erected onsite (which was subsequently removed from the property in…

FridayAug 24, 2018 2:01 pm

QualityStocksNewsBreaks – Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Provides Data Stream Integration on Mobile Platforms

Software development and mobile publishing company Consorteum Holdings (OTC: CSRH) is focused on the distribution of its the Universal Mobile Interface (“UMI”) to businesses that have a need for integrating data streams to generate revenue via mobile platforms. An article discussing the company reads: “Consorteum Holdings’ wholly owned subsidiary, 359 Mobile, Inc., is responsible for building the company’s UMI platform to blend any stream of data on a mobile platform, flexibly adapting to the diverse needs of a broad range of vertical markets, including e-commerce, mobile gaming, banking, data analytics, social media, entertainment and digital marketing.” To view the full…

FridayAug 24, 2018 12:40 pm

QualityStocksNewsBreaks – Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Drilling Toward Enormous Potential in Lithium Triangle

Lithium Chile (TSX.V: LITH) (OTCQB: LTMCF) is pleased with drilling progress and strong potential of the company’s Salar de Ollague project, with its first core and liquid samples being assayed. A recent article highlighting promising preliminary results reads, “How strong does the lithium brine need to be? Well, lithium brine is typically measured in parts per million (“ppm”), and this can alternatively be expressed as milligrams per liter (mg/L). At Albemarle’s massive lithium brine mine in the United States (http://ibn.fm/V2iZg), a concentration of lithium between 190 and 200 ppm has been sufficient for production. However, the first of Lithium Chile’s…

FridayAug 24, 2018 12:36 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Human Clinical Study Confirms Significant Delivery, Bioavailability Results

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) is pleased with recent significant results from a new human clinical study to evaluate its DehydraTECH™ powered TurboCBD™ and cannabidiol (CBD) fortified hemp oil capsules (http://ibn.fm/rPBS5). An article discussing this reads, “Results corroborate and confirm earlier in vitro and in vivo studies that evaluated DehydraTECH’s platform and measured higher levels of drug delivery achieved quicker than controls with matching CBD amounts. LXRP said that it believes nearly identical bioavailability enhancement results would be shown if the cannabinoid was THC instead of CBD.” To view the full article, visit http://ibn.fm/yn12L About Lexaria Bioscience Corp. Lexaria…

FridayAug 24, 2018 11:54 am

QualityStocksNewsBreaks – The Flowr Corp. Partners with Scotts Miracle-Gro Company (NYSE: SMG) Subsidiary to Conduct Cannabis Testing

The Flowr Corp., a Canadian licensed producer that focuses primarily on premium flower production, was recently highlighted in a Bloomberg article titled, “Scotts Miracle-Gro Tests Whether It Can Make Pot Grow Too,” authored by Kristine Owram. Per the article, Scotts Miracle-Gro Company’s (NYSE: SMG) subsidiary, Hawthorne Gardening Co., is partnering up with Flowr to build a 50,000-square-foot research facility on the same site as Flowr’s grow-op in Kelowna, British Columbia. Firstly, the new lab will test Hawthorne’s lights and nutrients on cannabis, with plans to ultimately conduct more in-depth studies on the plant. Currently producing 250 grams a square foot…

FridayAug 24, 2018 11:18 am

QualityStocksNewsBreaks – Payment Club Announces $7M Financing Through Partnership with Net Element, Inc. (NASDAQ: NETE) Subsidiary

Payment Club, Inc. this morning announced the completion of a $7 million financing led by its co-founders in partnership with Unified Payments, a subsidiary of Net Element (NASDAQ: NETE) and its institutional investor. Payment Club’s co-founders lead the financing with $2 million in equity. Unified Payments, through its partnership with its institutional investor, arranged a $5 million credit facility for Payment Club to drive its growth initiatives, bringing total debt and equity financing to $7 million. Payment Club intends to utilize the funding by expanding nationwide, hiring up to 100 membership advisors, and creating show rooms where business owners can gain information on the different…

FridayAug 24, 2018 10:36 am

QualityStocksNewsBreaks – Accelerated Technologies Holding Corp. (ATHC) Subsidiaries Drive Corporate Growth, Maximize Shareholder Value

Full-service end-to-end business solution and technology company Accelerated Technologies Holding Corp. (OTC: ATHC) recently detailed the expansion of its Intelagy subsidiary’s operations to include credit card processing and business solutions operations. An article discussing the company reads: “ATHC’s portfolio also includes subsidiaries XStreamCorp, a reality gaming social network that is adapting proprietary technologies to dramatically change the player experience in online gaming through streaming video, audio and messaging capabilities, and IconXchange, which aims to provide a decentralized, flexible infrastructure for human funding through blockchain-based coins and tokens. … The company provides consulting and technological resources along with venture capital to…

FridayAug 24, 2018 10:33 am

QualityStocksNewsBreaks – Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF) Optimistic about Upcoming Core Sample Assay Results

Vancouver-based mineral exploration company Marifil Mines (TSX.V: MFM) (OTCQB: MFMLF) is currently in anticipation of official assay results from numerous core samples taken during its diamond core drilling program at the San Roque property in Argentina. Company management is optimistic about “favorable results” from the impending results. An article discussing the company reads: “The drill cores taken during Marifil’s recent campaign are undergoing geological reporting procedures to retrieve data. Core sampling, involving sawing the product in half lengthways, is underway by field crews still in place. One half of each core will be shipped to labs in Mendoza, Argentina, for…

FridayAug 24, 2018 10:30 am

QualityStocksNewsBreaks – CytoDyn Inc. (CYDY) Developing Therapeutic Anti-Viral Agent as Potential Alternative to Current HIV Treatment Options

Biotechnology company CytoDyn (OTCQB: CYDY) remains focused on the development of its new anti-HIV treatment, PRO 140. An article discussing the company’s therapeutic anti-viral agent reads: “The development of PRO 140 is of particular interest, because it could allow people living with HIV to take just one weekly dose instead of the daily pills required by current therapies. … An antibody rather than a drug, PRO 140 works by blocking the most prevalent HIV subtype from entering healthy cells, thus protecting them from infection. Recognizing the treatment’s potential, the FDA has designated PRO 140 a fast-track candidate. To qualify for…

Site Search

Company Search

Category: QualityStocksNewsBreaks